Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptoki (Q43556056)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptoki |
scientific article |
Statements
1 reference
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptoki (English)
1 reference
1 reference
Topol EJ
1 reference
White HD
1 reference
Sadowski Z
1 reference
Barbash GI
1 reference
Reiner J
1 reference
Wilcox RG
1 reference
Morris D
1 reference
Aylward P
1 reference
Woodlief LH
1 reference
1 November 1995
1 reference
1 reference
Identifiers
1 reference